SCHEMBL8630659

SCHEMBL8630659

NCCC(C(=O)O)(c1ccccc1)N1CCN(c2ccncc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.40
DRD2 P14416 3/20 0.40
HRH3 Q9Y5N1 3/20 0.40
TRPV1 Q8NER1 1/20 0.40
SLC2A1 P11166 1/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2D6 P10635 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
AKR1C3 P42330 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
AOC3 Q16853 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8636972 0.76 CA12 (0.38) HRH3CYP2C9CYP2C19CYP2D6TSHR
SCHEMBL8686318 0.76 ITGB3 (0.43) HRH3CYP2C9CYP2C19ITGB3ITGA2B
SCHEMBL8701069 0.74 SLC2A1 (0.39) DRD2HRH3SLC2A1CYP2C9ALDH1A1
SCHEMBL8634147 0.74 SLC2A1 (0.40) HRH3TRPV1SLC2A1CYP2C9CYP2C19
SCHEMBL8633964 0.73 KDM4E (0.45) HRH3SLC2A1CYP2C9CYP2C19ALDH1A1
SCHEMBL8837939 0.73 ITGB3 (0.40) HTR1ADRD2HRH3SLC2A1ALDH1A1
Hydrochloric Acid SCHEMBL8838192 0.72 KDM4E (0.44) HRH3SLC2A1CYP2C9CYP2C19ALDH1A1
SCHEMBL8635415 0.72 HSD17B10 (0.39) HTR1ADRD2HRH3TRPV1CYP2C9
SCHEMBL7947612 0.70 F2 (0.42) HTR1ADRD2TRPV1SLC2A1CYP2C9
SCHEMBL8702212 0.70 CA12 (0.38) HTR1ADRD2HRH3CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5753659-A ANTICOAGULANTS FOR BLOOD DISORDER, CARDIOVASCULAR DISORDER, THROMBOSIS, ZENECA LIMITED (GB) 1998-05-19 US disclosed
US-5750754-A TERTIARY BUTYL 3-METHYL-4-SUBSTITUTED BUTYRATE; CHEMICAL INTERMEDIATES FOR ANTICAOGULANT DRUGS ZENECA LIMITED (GB) 1998-05-12 US disclosed